Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
2012
108 citations
Journal Article
Field-Weighted Citation Impact:
12.45
·
At Bristol
Piotr Tomczak
·
University Hospital of Lord’s Transfiguration
Seppo Pyrhönen
·
Turku University Hospital
Kate Fife
·
Cambridge University Health Partners
Petri Bono
·
Helsinki University Hospital
J Boxall
·
Mount Vernon Hospital
Thierry André
·
Bayer (Germany)
Michael Jeffers
·
Bayer (United States)
Tiffany Lin
·
Bayer (United States)
David I. Quinn
·
University of Southern California
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial | Researchclopedia